Eliminating cervical cancer depends on global effort to ensure supply meets demand

(Credit: Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Anuradha Gupta, Deputy CEO, Gavi, the Vaccine Alliance


  • COVID-19 has overshadowed the global movement to vaccinate against cervical cancer.
  • Greater access to HPV vaccine is needed, particularly in lower-income countries where demand has outstripped supply.
  • Lessons can be learned from the challenges of implementing the HPV vaccine in order to boost confidence and uptake of COVID-19 vaccines.

The COVID-19 pandemic has taught us something about how to prevent a disease that kills hundreds of thousands of women every year: we need enough vaccines to go around.

Against the backdrop of the worst pandemic in 100 years, the recent launch of a new global movement to defeat another disease may have gone unnoticed. As COVID-19 continues to escalate, demand for vaccines outstrips their initially limited supply and threatens to prolong the pandemic. We now need to ensure vaccine supply doesn’t become the biggest obstacle to this ambitious new global effort of (for the first time in human history) eliminating a cancer.

Cervical cancer is a deadly disease. Globally, it kills one woman every two minutes – more than 300,000 a year, and nearly all of them in low- and middle-income countries. These aren’t numbers: they are mothers, partners, daughters, sisters, friends. They are leaders, coworkers, neighbours, mentors. Every girl deserves protection against this terrible disease. But that’s not possible when there simply isn’t enough vaccine to go around.

As we have seen with COVID-19, once safe, effective vaccines are available, it’s essential that supply meets demand. But supply of vaccines against human papillomavirus (HPV), which protect against nearly all cases of cervical cancer, has been an ongoing challenge. This means that the global distribution of HPV vaccines is inequitable across geography, income and disease burden.

The relative lack of cervical cancer screening and treatment in many lower-income countries makes prevention through immunisation even more crucial than in higher-income countries. Thanks to work by my organisation, Gavi, the Vaccine Alliance, the HPV vaccine is affordable to lower-income countries – $4.50 per dose, compared with $100 in high-income countries. But price doesn’t matter if there’s not enough to buy. Vaccines, Health and healthcare, Gavi

What is the World Economic Forum doing about access to vaccines?

In 2000, Gavi, the Vaccine Alliance was launched at the World Economic Forum’s Annual Meeting in Davos, with an initial pledge of $750 million from the Bill and Melinda Gates Foundation.

The aim of Gavi is to make vaccines more accessible and affordable for all – wherever people live in the world.

Along with saving an estimated 10 million lives worldwide in less than 20 years,through the vaccination of nearly 700 million children, – Gavi has most recently ensured a life-saving vaccine for Ebola.

At Davos 2016, we announced Gavi’s partnership with Merck to make the life-saving Ebola vaccine a reality.

The Ebola vaccine is the result of years of energy and commitment from Merck; the generosity of Canada’s federal government; leadership by WHO; strong support to test the vaccine from both NGOs such as MSF and the countries affected by the West Africa outbreak; and the rapid response and dedication of the DRC Minister of Health. Without these efforts, it is unlikely this vaccine would be available for several years, if at all.

Read more about the Vaccine Alliance, and how you can contribute to the improvement of access to vaccines globally – in our Impact Story.

Lower-income countries provide valuable insights

Since 2012, Gavi has supported the introduction of the HPV vaccine for girls in 21 lower-income countries, with 10 more in the pipeline. Yet the access gap is still far too wide: as of 2020, less than 25% of low-income and less than 30% of lower middle-income countries had introduced the vaccine, compared with 85% of high-income countries. As we’ve learned from the COVID-19 vaccine race, unless sufficient, timely supply of vaccines is distributed equitably, confidence dips, insecurity rises and people in poor countries may not have the same chance at a healthy future.

Since the pandemic began (despite lockdowns) a spike in vaccine hesitancy and misinformation, and a severe contraction in the global economy, lower-income countries have demonstrated extraordinary resilience in the face of unprecedented challenges. In fact, there’s a lot that higher-income countries preparing to deploy COVID-19 vaccines can learn from lower-income countries about introducing a new vaccine in high demand – starting with how to prioritize high-risk individuals and groups.

For example, when lower-income countries were unable to vaccinate several ages at the same time because of paucity of HPV vaccine supply, they had to prioritize a single age. This is exactly what countries are doing now in deploying COVID-19 vaccines, in order to ensure that high-risk individuals, such as health care and other frontline workers, and vulnerable groups are the first to receive the protection they need. Once supply meets demand, that focus can be expanded.

Higher-income countries can also learn from the successes of lower-income countries in building confidence in, boosting demand for, and ensuring high coverage, of new vaccines – from community engagement, to TV dramas, to e-registers. Health professionals, civil society, religious leaders, social media and tech companies are key partners for governments and global health players in the roll-out of HPV vaccines.

Fight against cervical cancer

With the prize of eliminating cervical cancer in mind, in the long-term we may need to think about targeting further to ensure that the people most in need—those whose lives are most at risk—are given priority in the global context. Launched by the World Health Organization in November 2020, the “Global strategy to accelerate the elimination of cervical cancer as a public health problem” frames the fight against cervical cancer as a moral imperative: we must ensure that necessary health services continue despite the pandemic.

As 2021 begins, we can’t afford to lose one more life to a preventable, curable disease. And that means ensuring that a lack of supply of HPV vaccines to lower-income countries does not become the only barrier to this ambitious, but highly feasible, goal of eliminating cervical cancer – for good.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Pro-EU forces won a 70% triumph in the European elections

Greater EU Civil Protection capacity needed in light of lessons from COVID-19

The world’s impact in a small Brazilian town and the increased demand for mental health

What will education look like in 20 years? Here are 4 scenarios

High level political talks didn’t break the stalemate in Ukraine

EU officially launches its first naval mission against migrant smugglers

Half the world’s refugee children not in school, UN agency finds

What does Tsipras have to offer to the rest of Europe? Is it worth an early advance of €10 billion? Berlin sturdily denies it

Spread Her Wings: Let Her Fly

This is the environmental catastrophe you’ve probably never heard of

Protecting farmers and quality products: vote on EU farm policy reform plans

Donors must do more to align development finance with climate goals

Can the Notre-Dame fire freeze the ‘Yellow Vests’ uprising?

What we need is more (and better) multilateralism, not less

ICC Appeals Chamber acquits former Congolese Vice President Bemba from war crimes charges

Venezuelan exodus to Ecuador reaches record levels: UN refugee agency steps up aid

Here’s how innovation could help car companies hit by COVID-19

Adriatic Sea: MEPs adopt multiannual plan for fisheries

GSMA Mobile 360 Series – Latin America, in association with The European Sting

How the Fourth Industrial Revolution can help us beat COVID-19

Dutch voters reject EU-Ukraine partnership and open a new pandora’s box for the EU

How we can embrace the electrical vehicle transition by adopting smart charging

Trade in fake Italian goods costs economy billions of euros

No hard drivers in sight to remodel the stagnating affairs of the EU

Charges against Baha’i in Yemen must be dropped: UN experts urge release of detainees

Conditions deteriorating alarmingly in Yemen, warns senior UN official

Six months after the Beirut port explosion: reflections from a first responder

5 things you need to know about your microbiome

GREXIT final wrap-up: nobody believed Aesop’s boy who cried wolf so many times

EU Parliament raises burning issues over the FTA with the US

UN Security Council hails ‘courage’ of Afghan voters

TTIP is not dead as of yet, the 15th round of negotiations in New York shouts

The Tears of lovely Memories

Parliament elects the von der Leyen Commission

Boosting the EU’s Green Recovery: EU invests over €2 billion in 140 key transport projects to jump-start the economy

The Great Reset needs great leaders to help the most vulnerable

How global tech can drive local healthcare innovation in China

EU elections 2019: Rise of nationalist trends and populism in Europe challenges the EU edifice

MEPs back measures to reconcile career and private life

Fostering global citizenship in medical students through exchanges

Brazilian officer a ‘stellar example’ of why more women are needed in UN peacekeeping

Dreaming of China

Code of Practice on Disinformation one year on: online platforms submit self-assessment reports

South Asia can become an innovation hub. Here’s how

First calls under Horizon Europe to be launched by the European Research Council

European Commission calls on national political parties to join efforts to ensure free and fair elections in Europe

An American duel in Brussels: Salesforce against Microsoft over Linkedin deal

How Mobile Technology is Changing the Healthcare System

SRHR the indispensable ally in ending HIV

Mental health in the pandemic: how to stay emotionally stable?

Suicide Prevention: Using Graduation as a Transformative Tool

As the inventor of copy and paste dies, here are other computing innovations we take for granted

Give a chance to the brothers of Ailan: reception of refugees in Greece

Rare diseases are more common than you might think

Coronavirus: rescEU medical stockpile expands in four Member States

Finland has giant supermarkets that only stock second-hand goods

Working Muslim women are a trillion-dollar market

Why does the whole world want Britain to stay in the EU?

New rules make household appliances more sustainable

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s